The Cancer Diagnostics stage will demonstrate how we can utilise the advances in molecular profiling of cancers, and their complexity, to improve the way you diagnose and treat cancer in the clinical setting, with a focus on improving precision medicine for better patient outcomes.
11:30
-
Cancer Diagnostics Stage30 minsUncover how integrating epigenomic data with genomic, transcriptomic, and proteomic data provides a comprehensive understanding of molecular alterations in renal and breast cancers. Highlight how mult ...
)
12:00
-
Cancer Diagnostics Stage30 mins
12:30
-
Cancer Diagnostics Stage30 minsBreast cancer now undergoes routine molecular phenotyping leading to improved prognostication and use of targeted therapies Liquid biopsies are increasing being used for research and clinical care. Da ...
)
13:00
-
Cancer Diagnostics Stage85 mins
14:25
-
Cancer Diagnostics Stage30 minsThis talk will demonstrate how methylation biomarkers can be detected from liquid biopsy tests to support early cancer detection and monitoring. Using methylation based liquid biopsies as a tumour n ...
)
14:55
-
Cancer Diagnostics Stage30 minsTBC
15:25
-
Cancer Diagnostics Stage30 minsLiquid biopsies could improve cancer detection and monitoring but require higher sensitivity First, I will describe a tumor-informed, whole-genome, mutation enrichment sequencing test for minimal resi ...
)
15:55
-
Cancer Diagnostics Stage30 mins
16:25
-
Cancer Diagnostics Stage30 minsUsing a multi-modal approach to liquid biopsy combining genomics, epigenomics and fragmentomic assays applied to several precision medicine applications. Demonstrating the utility of this analysis for ...
)
16:55
-
Cancer Diagnostics Stage30 minsTBC
17:25
-
Cancer Diagnostics Stage30 minsIncorporation of MRD in the CDP life cycle and beyond for solid and hematologic cancers You will learn how next generation algorithms are used for patient stratification
)
11:30
-
Cancer Diagnostics Stage30 minsEstablishing liquid biopsies for early cancer detection and screening. Where can they most provide value. MCEDs currently available? How are liquid biopsies optimising cancer diagnosis. How can we acc ...
)
)
)
12:00
-
Cancer Diagnostics Stage30 minsTBC
12:30
-
Cancer Diagnostics Stage30 minsNegative selection-based microfluidic technologies enable high resolution multi-omic profiling of rare CTCs from patient blood Single cell RNA-seq of CTCs from patients with prostate cancer can be use ...
)
13:00
-
Cancer Diagnostics Stage70 mins
14:10
-
Cancer Diagnostics Stage30 minsMass-spectrometry-based proteomic analysis on extracellular vesicles to uncover new biomarkers to support the diagnosis and management of genitourinary cancers. Using these EV-derived biomarkers to ...
)
14:40
-
Cancer Diagnostics Stage30 minsThe emerging promise of T cell receptor therapies (TCR-Ts) for cancer treatment Navigating challenges of predictive biomarkers for TCR-T cell therapy Key considerations for the successful development ...
)
15:10
-
Cancer Diagnostics Stage30 minsJemperli (dostarlimab), an immunotherapy received FDA's "Breakthrough Therapy Designation" for treating rectal cancer with specific genetic traits (MMRd/MSI-high), showing 100% remission in trial pati ...
)